Axsome Therapeutics, Inc. (AXSM)
168.47
-1.61
(-0.95%)
USD |
NASDAQ |
Oct 09, 16:00
168.47
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Max Drawdown (5Y) : 79.54% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 79.54% |
| August 31, 2026 | 79.54% |
| July 31, 2026 | 81.26% |
| June 30, 2026 | 81.26% |
| May 31, 2026 | 81.26% |
| April 30, 2026 | 81.26% |
| March 31, 2026 | 81.26% |
| February 28, 2026 | 81.26% |
| January 31, 2026 | 81.26% |
| December 31, 2025 | 81.26% |
| November 30, 2025 | 81.26% |
| October 31, 2025 | 81.26% |
| September 30, 2025 | 81.26% |
| August 31, 2025 | 81.26% |
| July 31, 2025 | 81.26% |
| June 30, 2025 | 81.26% |
| May 31, 2025 | 81.26% |
| April 30, 2025 | 81.26% |
| March 31, 2025 | 81.26% |
| February 28, 2025 | 81.26% |
| January 31, 2025 | 81.26% |
| December 31, 2024 | 81.26% |
| November 30, 2024 | 81.26% |
| October 31, 2024 | 81.26% |
| September 30, 2024 | 81.26% |
| Date | Value |
|---|---|
| August 31, 2024 | 81.26% |
| July 31, 2024 | 81.26% |
| June 30, 2024 | 81.26% |
| May 31, 2024 | 81.26% |
| April 30, 2024 | 81.26% |
| March 31, 2024 | 81.26% |
| February 29, 2024 | 81.26% |
| January 31, 2024 | 81.26% |
| December 31, 2023 | 82.44% |
| November 30, 2023 | 86.65% |
| October 31, 2023 | 86.65% |
| September 30, 2023 | 86.65% |
| August 31, 2023 | 86.65% |
| July 31, 2023 | 86.65% |
| June 30, 2023 | 86.65% |
| May 31, 2023 | 86.65% |
| April 30, 2023 | 86.65% |
| March 31, 2023 | 86.65% |
| February 28, 2023 | 86.65% |
| January 31, 2023 | 86.65% |
| December 31, 2022 | 86.65% |
| November 30, 2022 | 86.65% |
| October 31, 2022 | 86.65% |
| September 30, 2022 | 86.65% |
| August 31, 2022 | 86.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Eli Lilly & Co. | 34.47% |
| Filana Therapeutics, Inc. | 99.34% |
| CorMedix, Inc. | 84.47% |
| Eloxx Pharmaceuticals, Inc. | 100.0% |
| Breakthrough Chemistry, Inc. | 99.04% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 28.74 |
| Beta (5Y) | 0.8577 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 66.40% |
| Historical Sharpe Ratio (5Y) | 0.5621 |
| Historical Sortino (5Y) | 1.320 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 20.55% |